A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

PHASE2CompletedINTERVENTIONAL
Enrollment

801

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

June 7, 2024

Study Completion Date

October 14, 2024

Conditions
Measles; Mumps; Rubella; ChickenpoxMeasles
Interventions
BIOLOGICAL

Investigational MMRV(H)NS vaccine

1 dose of a measles, mumps, and rubella at release potency and VNS at high (H) potency vaccine administered subcutaneously.

BIOLOGICAL

Investigational MM(H)RVNS vaccine

1 dose of a measles, rubella, and varicella at release potency and mumps at high (H) potency vaccine administered subcutaneously.

BIOLOGICAL

Investigational M(L)M(L)R(L)V(L)NS vaccine

1 dose of measles, mumps, rubella, and varicella, all at low (L) potency vaccine administered subcutaneously.

BIOLOGICAL

Marketed MMRV_Lot 1 and Lot 2 vaccine

1 dose of a marketed measles, mumps, rubella, and varicella of Lot 1 or 1 dose of a marketed measles, mumps, rubella, and varicella of Lot 2 vaccine administered subcutaneously.

Trial Locations (47)

333

GSK Investigational Site, Taoyuan District

407

GSK Investigational Site, Taichung

909

GSK Investigational Site, San Juan

10002

GSK Investigational Site, Taipei

10449

GSK Investigational Site, Taipei

13210

GSK Investigational Site, Syracuse

29681

GSK Investigational Site, Simpsonville

33014

GSK Investigational Site, Miami Lakes

33613

GSK Investigational Site, Tampa

35235

GSK Investigational Site, Birmingham

37388

GSK Investigational Site, Tullahoma

38007

GSK Investigational Site, Bogotá

40291

GSK Investigational Site, Louisville

40447

GSK Investigational Site, Taichung

44121

GSK Investigational Site, Cleveland

45414

GSK Investigational Site, Dayton

48025

GSK Investigational Site, Bingham Farms

48201

GSK Investigational Site, Detroit

68114

GSK Investigational Site, Omaha

68505

GSK Investigational Site, Lincoln

68522

GSK Investigational Site, Lincoln

70508

GSK Investigational Site, Lafayette

72401

GSK Investigational Site, Jonesboro

77469

GSK Investigational Site, Richmond

77539

GSK Investigational Site, Dickinson

78504

GSK Investigational Site, McAllen

83404

GSK Investigational Site, Idaho Falls

83406

GSK Investigational Site, Ammon

84041

GSK Investigational Site, Layton

84067

GSK Investigational Site, Roy

84095

GSK Investigational Site, South Jordan

84604

GSK Investigational Site, Provo

90255

GSK Investigational Site, Huntington Park

90706

GSK Investigational Site, Bellflower

91790

GSK Investigational Site, West Covina

94611

GSK Investigational Site, Oakland

95051

GSK Investigational Site, Santa Clara

95119

GSK Investigational Site, San Jose

95661

GSK Investigational Site, Roseville

95815

GSK Investigational Site, Sacramento

95823

GSK Investigational Site, Sacramento

760002

GSK Investigational Site, Barranquilla

02118

GSK Investigational Site, Boston

080020

GSK Investigational Site, Barranquilla

LV1002

GSK Investigational Site, Riga

00907

GSK Investigational Site, San Juan

00918

GSK Investigational Site, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY